MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 20, 2019 at 9:52 AM.

  1. #1 cafead, May 20, 2019 at 9:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via The Medicines Co. and partner Alnylam Pharmaceuticals have presented new evidence supporting the long-term use of their RNA-based cholesterol lowering therapy inclisiran, which is meant to be a longer lasting alternative to a new crop of heart drugs called PCSK9 inhibitors.

    article source
     
    Quote

Reply to Thread